IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript March 17, 2026 IceCure Medical Ltd misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $-0.05. Operator: ...
Discover how CRISPR genome editing is revolutionizing medicine. Learn the science of Cas9, current clinical trials, and the future of gene editing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results